Eomes-Dependent Loss of the Co-activating Receptor CD226 Restrains CD8+ T Cell Anti-tumor Functions and Limits the Efficacy of Cancer Immunotherapy
Author:
Marianne Weulersse,Assia Asrir,Andrea C. Pichler,Lea Lemaitre,Matthias Braun,Nadège Carrié,Marie-Véronique Joubert,Marie Le Moine,Laura Do Souto,Guillaume Gaud,Indrajit Das,Elisa Brauns,Clara M. Scarlata,Elena Morandi,Ashmitha Sundarrajan et al.